Structure Therapeutics Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-02

Reporting Person: TETLOW SHARON (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$2.79	2032-05-11	Ordinary Shares (80000)		Direct

Footnotes

F1: 1/4th of the shares shall vest one year after March 14, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.